novel treatment paradigms for aml at ash 2021
Published 2 years ago • 269 plays • Length 1:01Download video MP4
Download video MP3
Similar videos
-
1:42
novel treatment combinations in aml: what’s to come?
-
2:29
epitope editing enables the use of novel immunotherapies for aml
-
3:02
novel treatments and ongoing clinical trials for wm: targeted agents and immunotherapies
-
2:33
novel immunotherapies in aml and insights into the future of the treatment landscape
-
1:17
exciting novel treatments being developed for mds
-
3:40
how the aml treatment landscape has evolved with the use of novel combination therapies
-
2:54
how novel agents & individualized treatment approaches are improving outcomes in patients with aml
-
1:50
novel treatment regimens under investigation for richter's transformation
-
1:34
cctx-001: a novel car-t therapy for aml
-
5:08
finding novel treatment options for relapsed/progressing aml
-
16:35
key highlights in mpns at ash 2023: novel agents & combinations, ongoing clinical trials, and more
-
1:21
novel targets for aml
-
1:29
the current landscape of immunotherapy for aml: an update from ash 2023
-
3:19
an overview of novel treatment approaches in tp53-mutated aml
-
1:30
evaluating the optimal duration of cpx-351 treatment & best timing for allosct consolidation in aml
-
0:52
a real-world study of the optimal duration of cpx-351 treatment in patients with aml
-
0:49
novel targets for car-t therapy in mcl
-
0:55
the role of rna modifications in mds and aml